Patient engagement, equipoise, informed consent, ethics board, monitoring, reporting/release of data in the literature, compassionate/expanded access; patient foundations, liaisons and advocates. Engaging with Indigenous communities and special populations. Considerations around translational research, generics, biosimilars, and labeling.